New eye injection trial aims to halt vision loss from diabetes and clots
NCT ID NCT07259928
Summary
This study is testing a new drug called ANXV to see if it is safe and might help people with two serious eye conditions: diabetic retinopathy and retinal vein occlusion. A small group of 12 adults will receive the drug as a slow injection into a vein for five days and be monitored for four months. The main goals are to check for side effects and see if the treatment improves vision or reduces the need for other medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINAL VEIN OCCLUSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Retina Clinic London
RECRUITINGLondon, W1G9AX, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.